Search Results - "Diamantopoulos, N."

Mode-selective optical packet switching in mode-division multiplexing networks by Diamantopoulos, N P, Hayashi, M, Yoshida, Y, Maruta, A, Maruyama, R, Kuwaki, N, Takenaga, K, Uemura, H, Matsuo, S, Kitayama, K

“…A novel mode-selective optical packet switching, based on mode-multiplexers/demultiplexers and multi-port optical micro-electro-mechanical systems (MEMS)…”
Get full text

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies by Diamantopoulos, Leonidas N, Kalligeros, Markos, Halfdanarson, Thorvardur R, Diamantis, Nikolaos, Toumpanakis, Christos

“…There is an evolving landscape of systemic combination regimens for patients with advanced well-differentiated gastroenteropancreatic neuroendocrine tumors…”
Get full text

HLA-A03 and response to immune checkpoint blockade in patients with cancer by Diamantopoulos, Leonidas N, Appleman, Leonard J

Get full text

Testicular germ cell tumors by Diamantopoulos, N, Kortsaris, A

“…Testicular cancer is the most frequent solid tumor in young male adults and a disease with elusive pathogenesis. Germ cell tumors represent 95% of all…”
Get more information

Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with checkpoint inhibitors by Khaki, Ali Raza, Li, Ang, Diamantopoulos, Leonidas N, Bilen, Mehmet A., Santos, Victor, Esther, John, Morales-Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J, Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A, Sankin, Alex, Rodriguez-Vida, Alejo, Lythgoe, Mark, Pinato, David J., Drakaki, Alexandra, Joshi, Monika, Velho, Pedro Isaacsson, Hahn, Noah, Liu, Sandy, Buznego, Lucia Alonso, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Baratam, Praneeth, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D., Sonpavde, Guru, Yu, Evan Y, Shankaran, Veena, Lyman, Gary H, Grivas, Petros

“…Multi-institution retrospective cohort study showed that patients with ECOG PS ≥2 (compared to ECOG PS 0–1) had comparable overall response rate but worse…”
Get full text

Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors by Khaki, Ali Raza, Li, Ang, Diamantopoulos, Leonidas N., Bilen, Mehmet A., Santos, Victor, Esther, John, Morales‐Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A., Sankin, Alex, Rodriguez‐Vida, Alejo, Lythgoe, Mark, Pinato, David J., Drakaki, Alexandra, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Liu, Sandy, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Baratam, Praneeth, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D., Sonpavde, Guru, Yu, Evan Y., Shankaran, Veena, Lyman, Gary H., Grivas, Petros

“…Background Immune checkpoint inhibitors (ICIs) represent an appealing treatment for patients with advanced urothelial cancer (aUC) and a poor performance…”
Get full text

Bleomycin cardiotoxicity during chemotherapy for an ovarian germ cell tumor by Didagelos, M, Boutis, A, Diamantopoulos, N, Sotiriadou, M, Fotiou, C

“…Platinum-based chemotherapeutic regimens, including BEP (bleomycin, etoposide, cisplatin) represent the standard of care, first line therapy in non-epithelial…”
Get full text

Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer by Andreadis, Charalampos, Charalampidou, Martha, Diamantopoulos, Nikolaos, Chouchos, Nikolaos, Mouratidou, Despina

“…A 33-year-old woman with T4cN3 breast cancer with metastases in the skeleton (M1) received five cycles of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC…”
Get full text

ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institution by Korentzelos, Dimitrios, Elishaev, Esther, Zhao, Chengquan, Jones, Mirka W., Soong, T. Rinda, Lesnock, Jamie, Orellana, Taylor, Zeccola, Alison, Diamantopoulos, Leonidas N., Wald, Abigail I., Bhargava, Rohit

“…Undifferentiated/dedifferentiated endometrial carcinomas (UDEC and DDEC) are rare, aggressive uterine neoplasms, with no specific line of differentiation. A…”
Get full text

Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinoma by Diamantopoulos, Leonidas N., Makrakis, Dimitrios, Korentzelos, Dimitrios, Alevizakos, Michail, Wright, Jonathan L., Grivas, Petros, Bountziouka, Vasiliki, Vadikolias, Konstantinos, Lambropoulou, Maria, Tripsianis, Gregory

“…•We present the first prognostic nomograms for overall survival/disease-specific survival in patients with sarcomatoid urothelial carcinoma.•Our nomograms are…”
Get full text

Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study by Miller, Natalie J, Khaki, Ali Raza, Diamantopoulos, Leonidas N, Bilen, Mehmet A, Santos, Victor, Agarwal, Neeraj, Morales-Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J, Shreck, Evan, Assi, Hussein, Gartrell, Benjamin A, Sankin, Alex, Rodriguez-Vida, Alejo, Lythgoe, Mark, Pinato, David J, Drakaki, Alexandra, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Liu, Sandy, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Jain, Jayanshu, Murgic, Jure, Barata, Pedro, Tripathi, Abhishek, Zakharia, Yousef, Galsky, Matthew D, Sonpavde, Guru, Yu, Evan Y, Lyman, Gary H, Grivas, Petros

“…Urinary tract cancer can be pure urothelial carcinoma, pure nonurothelial carcinoma or variant urothelial carcinoma (defined here as mixed urothelial…”
Get full text

High-Baud-Rate Direct Modulation of Membrane Laser on SiC under Uncooled Condition by Yamaoka, S., Diamantopoulos, N.-P., Nishi, H., Fujii, T., Takeda, K., Hiraki, T., Kanazawa, S., Kakitsuka, T., Matsuo, S.

“…We review recently developed membrane lasers on a SiC substrate. Due to the high thermal dissipation, high optical confinement, and an additional optical…”
Get full text

Knowledge and attitude of the Greek educational community toward epilepsy and the epileptic student by Kaleyias, J., Tzoufi, M., Kotsalis, C., Papavasiliou, A., Diamantopoulos, N.

“…The purpose of this study was to investigate primary and secondary school teachers’ knowledge of and attitudes toward epilepsy and the epileptic child. A…”
Get full text

Sarcomatoid Urothelial Carcinoma: A Population-Based Study of Clinicopathologic Characteristics and Survival Outcomes by Diamantopoulos, Leonidas N., Korentzelos, Dimitrios, Alevizakos, Michail, Wright, Jonathan L., Grivas, Petros, Appleman, Leonard J

“…Sarcomatoid urothelial carcinoma (SUC) is a rare and aggressive variant of bladder cancer with limited data regarding epidemiology and survival. In this study,…”
Get full text

Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration by Ravi, Praful, Pond, Gregory R., Diamantopoulos, Leonidas N., Su, Christopher, Alva, Ajjai, Jain, Rohit K., Skelton, William P., Gupta, Sumati, Tward, Jonathan D., Olson, Kathleen M., Singh, Parminder, Grunewald, Camilla M., Niegisch, Guenter, Lee, Jae‐Lyun, Gallina, Andrea, Bandini, Marco, Necchi, Andrea, Mossanen, Matthew, McGregor, Bradley A., Curran, Catherine, Grivas, Petros, Sonpavde, Guru P.

“…Objectives To evaluate outcomes of patients achieving a post‐treatment pathological stage of <ypT2N0 at radical cystectomy (RC) following neoadjuvant…”
Get full text

Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma by Makrakis, Dimitrios, Bakaloudi, Dimitra Rafailia, Talukder, Rafee, Lin, Genevieve Ihsiu, Diamantopoulos, Leonidas N., Jindal, Tanya, Vather-Wu, Naomi, Zakharia, Yousef, Tripathi, Nishita, Agarwal, Neeraj, Dawsey, Scott, Gupta, Shilpa, Lu, Eric, Drakaki, Alexandra, Liu, Sandy, Zakopoulou, Roubini, Bamias, Aristotelis, Fulgenzi, Claudia-Maria, Cortellini, Alessio, Pinato, David, Barata, Pedro, Grivas, Petros, Khaki, Ali Raza, Koshkin, Vadim S.

“…•Patients with advanced urothelial cancer (aUC) rechallenged with an ICI-based regimen may achieve disease control.•Rechallenge with ICI-based therapy in aUC…”
Get full text

Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the Literature by Diamantopoulos, Leonidas N., Khaki, Ali R., Sonpavde, Guru P., Venur, Vyshak A., Yu, Evan Y., Wright, Jonathan L., Grivas, Petros

“…Central nervous system (CNS) metastasis in patients with urothelial carcinoma (UC) is uncommon and poorly understood. We aimed to explore the clinical behavior…”
Get full text

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience by Bakaloudi, Dimitra Rafailia, Talukder, Rafee, Lin, Genevieve Ihsiu, Makrakis, Dimitrios, Diamantopoulos, Leonidas N., Tripathi, Nishita, Agarwal, Neeraj, Zakopoulou, Roubini, Bamias, Aristotelis, Brown, Jason R., Pinato, David J., Korolewicz, James, Jindal, Tanya, Koshkin, Vadim S., Murgić, Jure, Miletić, Marija, Frobe, Ana, Johnson, Jeffrey, Zakharia, Yousef, Drakaki, Alexandra, Rodriguez-Vida, Alejo, Rey-Cárdenas, Macarena, Castellano, Daniel, Buznego, Lucia Alonso, Duran, Ignacio, Carballeira, Clara Castro, Barrera, Rafael Morales, Marmorejo, David, McKay, Rana R., Stewart, Tyler, Gupta, Shilpa, Ruplin, Andrew Thomas, Yu, Evan Y., Khaki, Ali R., Grivas, Petros

“…Platinum-based chemotherapy (PBC) followed by avelumab switch maintenance in nonprogressors is standard first line (1L) treatment for advanced urothelial…”
Get full text

Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort Study by Bakaloudi, Dimitra Rafailia, Koehne, Elizabeth L., Diamantopoulos, Leonidas N., Holt, Sarah K., Sekar, Rishi R., Ghali, Fady, Vakar-Lopez, Funda, Nyame, Yaw A., Psutka, Sarah P., Gore, John L., de la Calle, Claire M., Lin, Daniel W., Schade, George R., Liao, Jay J., Hsieh, Andrew C., Yezefski, Todd, Hawley, Jessica E., Yu, Evan Y., Montgomery, R. Bruce, Grivas, Petros, Wright, Jonathan L.

“…Small cell bladder cancer (SCBC) is a rare histologic subtype with relative paucity of data regarding treatment response and outcomes. We reviewed 2 databases…”
Get full text

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors by Khaki, Ali Raza, Li, Ang, Diamantopoulos, Leonidas N., Miller, Natalie J., Carril-Ajuria, Lucia, Castellano, Daniel, De Kouchkovsky, Ivan, Koshkin, Vadim, Park, Joseph, Alva, Ajjai, Bilen, Mehmet A., Stewart, Tyler, Santos, Victor, Agarwal, Neeraj, Jain, Jayanshu, Zakharia, Yousef, Morales-Barrera, Rafael, Devitt, Michael, Nelson, Ariel, Hoimes, Christopher J., Shreck, Evan, Gartrell, Benjamin A., Sankin, Alex, Tripathi, Abhishek, Zakopoulou, Roubini, Bamias, Aristotelis, Rodriguez-Vida, Alejo, Drakaki, Alexandra, Liu, Sandy, Kumar, Vivek, Lythgoe, Mark P., Pinato, David J., Murgic, Jure, Fröbe, Ana, Joshi, Monika, Isaacsson Velho, Pedro, Hahn, Noah, Alonso Buznego, Lucia, Duran, Ignacio, Moses, Marcus, Barata, Pedro, Galsky, Matthew D., Sonpavde, Guru, Yu, Evan Y., Shankaran, Veena, Lyman, Gary H., Grivas, Petros

“…While immune checkpoint inhibitors (ICIs) are approved in the first-line (1L) setting for cisplatin-unfit patients with programmed death-ligand 1 (PD-L1)-high…”
Get full text